- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Tenofovir with emtricitiabine and efavirenz; tenofovir with emtricitabine and rilpivirine; tenofovir with emtricitabine, elvitagrevir and cobicistat – March 2019
Tenofovir with Emtricitabine and Efavirenz: Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and efavirenz 600 mg; Atripla®; Tenofovir with Emtricitabine and Rilpivirine: Tablet containing tenofovir disoproxil fumarate
Last updated
5 July 2019